IN-UTERO TREATMENT OF FETAL GOITROUS HYPOTHYROIDISM CAUSED BY MATERNAL GRAVES-DISEASE

被引：8
|
作者：
HADI, HA [1 ]
STRICKLAND, D [1 ]
机构：
[1] E CAROLINA UNIV,SCH MED,DEPT OBSTET & GYNECOL,DIV MATERNAL FETAL MED,GREENVILLE,NC
来源：
AMERICAN JOURNAL OF PERINATOLOGY | 1995年 / 12卷 / 06期
关键词：
GRAVES DISEASE; FETAL GOITROUS HYPOTHYROIDISM; THYROXINE; CARDOCENTESIS;
D O I：
10.1055/s-2007-994520
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
We present two cases of maternal Craves' disease complicated by fetal goitrous hypothyroidism. Both patients had elevated maternal thyroid-stimulating immunoglobulin and thyrotropic-binding inhibitory immunoglobulin antibody titers. Diagnosis of fetal hypothyroidism was made by cordocentesis, and serial injections of thyroxine into the amniotic fluid resulted in return to normal of fetal thyroid size and function at birth. Significance of in utero management of fetal hypothyroidism is discussed.
引用
收藏
页码：455 / 458
页数：4
相关论文
共 41 条
  • [31] Correlation Between TRAb and Early Onset Hypothyroidism After 131 I Treatment for Graves' Disease
    Song, Qi
    Fang, Zhouyu
    Wang, Shurong
    Liu, Zhihua
    Xiao, Wenjin
    Zong, Haijun
    Xie, Ying
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (11) : 779 - 784
  • [32] Predictive factors influencing hypothyroidism following the radioactive iodine treatment of Graves' disease in different periods
    Zhao, Aomei
    Zhang, Jing
    Xue, Jianjun
    Lu, Xueni
    Wang, Qi
    Ji, Ting
    Yang, Lulu
    Yu, Yan
    Yang, Aimin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Hypothyroidism During Antithyroid Drug Treatment with Methimazole is a Favorable Prognostic Indicator in Patients with Graves' Disease
    Choo, Young Kwang
    Yoo, Won Sang
    Kim, Dong Woo
    Chung, Hyun-Kyung
    THYROID, 2010, 20 (09) : 949 - 954
  • [34] DYNAMIC CHANGES IN SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS DURING TREATMENT OF GRAVES-DISEASE - CORRELATION WITH DISEASE-ACTIVITY
    WERYHA, G
    GOBERT, B
    LECLERE, J
    BENE, MC
    FAURE, G
    HARTEMANN, P
    HORMONE RESEARCH, 1991, 35 (01) : 8 - 12
  • [35] Quality of life and decision regret in patients with late-hypothyroidism after radioiodine treatment for Graves' disease
    Li, Yue
    Yang, Tianyu
    Ju, Linjun
    Feng, Yuyue
    Chen, Zheng
    Xiang, Xing
    Zhu, Tao
    Pang, Hua
    Wang, Zhengjie
    CLINICAL ENDOCRINOLOGY, 2024, 100 (01) : 87 - 95
  • [36] Failure of radioiodine treatment in Graves’ disease intentionally caused by a patient: Suspected Munchausen syndrome
    Seigo Kinuya
    Takatoshi Michigishi
    Kenichi Nakajima
    Keiko Kinuya
    Akira Seto
    Ichiei Kuji
    Kunihiko Yokoyama
    Norihisa Tonami
    Annals of Nuclear Medicine, 2004, 18 : 631 - 632
  • [37] Failure of radioiodine treatment in Graves' disease intentionally caused by a patient: Suspected Munchausen syndrome
    Kinuya, S
    Michigishi, T
    Nakajima, K
    Kinuya, K
    Seto, A
    Kuji, I
    Yokoyama, K
    Tonami, N
    ANNALS OF NUCLEAR MEDICINE, 2004, 18 (07) : 631 - 632
  • [38] BODY-COMPOSITION ASSESSED BY BIOELECTRICAL-IMPEDANCE ANALYSIS (BIA) IN PATIENTS WITH GRAVES-DISEASE BEFORE AND AFTER TREATMENT
    HU, HY
    KATO, Y
    ENDOCRINE JOURNAL, 1995, 42 (04) : 545 - 550
  • [39] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS BEFORE AND AFTER SURGICAL-TREATMENT FOR GRAVES-DISEASE
    MURAKAMI, S
    KOBAYASHI, A
    KUMA, K
    MURAI, H
    OKAMURA, Y
    SATOMI, A
    ISHIDA, K
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1995, 25 (01): : 55 - 58
  • [40] Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves' disease: case report
    Elsherbiny, Tamer Mohamed
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2024, 15
12345